NIH-funded research P01 program project

Understanding genetic factors in immune system diseases

Official title: Polygenic contributors to disease expressivity in genetic errors of immunity

Funded at Washington University · NIH-11010139 · Data updated 2026-11-12

This study is looking at how your genes might affect the severity of immune system diseases, with the hope of finding better ways to diagnose and treat patients before they experience serious symptoms.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startApril 8, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$413,984
NIH project number1P01AI186771-01
Project IDNIH-11010139 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with genetic errors of immunity, including those with varying degrees of autoimmunity, inflammation, and atopy.

Less likely to help

Patients with immune system disorders that are not genetically based or those without a clear genetic component may not benefit from this research.

What this research studies

This research investigates how genetic variations influence the severity and expression of diseases related to the immune system. By analyzing polygenic risk scores and specific genetic variants, the study aims to predict how these factors affect the clinical outcomes of patients with genetic errors of immunity. The approach includes advanced genetic analysis and the exploration of treatment options like precision therapies and stem cell transplantation, which could improve patient management and outcomes. The goal is to enhance early diagnosis and treatment strategies for patients before severe symptoms develop.

Why it matters

Potential benefit: If successful, this research could lead to more accurate predictions of disease severity and better-targeted treatments for patients with immune system disorders.

How similar studies have gone: Previous research has shown promise in using genetic risk factors to predict disease outcomes in similar immune-related conditions, indicating that this approach may yield valuable insights.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Milner, Joshua D. — Washington University
  • Study coordinator: Milner, Joshua D.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.